The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iwakoshi, N. N.
Right arrow Articles by Greiner, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iwakoshi, N. N.
Right arrow Articles by Greiner, D. L.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Blood Transfusion and Donation
The Journal of Immunology, 2000, 164: 512-521.
Copyright © 2000 by The American Association of Immunologists

Treatment of Allograft Recipients with Donor-Specific Transfusion and Anti-CD154 Antibody Leads to Deletion of Alloreactive CD8+ T Cells and Prolonged Graft Survival in a CTLA4-Dependent Manner1

Neal N. Iwakoshi, John P. Mordes, Thomas G. Markees, Nancy E. Phillips, Aldo A. Rossini2 and Dale L. Greiner

Diabetes Division, University of Massachusetts Medical School, Worcester, MA 01655

A two-element protocol consisting of one donor-specific transfusion (DST) plus a brief course of anti-CD154 mAb greatly prolongs the survival of murine islet, skin, and cardiac allografts. To study the mechanism of allograft survival, we determined the fate of tracer populations of alloreactive transgenic CD8+ T cells in a normal microenvironment. We observed that DST plus anti-CD154 mAb prolonged allograft survival and deleted alloreactive transgenic CD8+ T cells. Neither component alone did so. Skin allograft survival was also prolonged in normal recipients treated with anti-CD154 mAb plus a depleting anti-CD8 mAb and in C57BL/6-CD8 knockout mice treated with anti-CD154 mAb monotherapy. We conclude that, in the presence of anti-CD154 mAb, DST leads to an allotolerant state, in part by deleting alloreactive CD8+ T cells. Consistent with this conclusion, blockade of CTLA4, which is known to abrogate the effects of DST and anti-CD154 mAb, prevented the deletion of alloreactive transgenic CD8+ T cells. These results document for the first time that peripheral deletion of alloantigen-specific CD8+ T cells is an important mechanism through which allograft survival can be prolonged by costimulatory blockade. We propose a unifying mechanism to explain allograft prolongation by DST and blockade of costimulation.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
D. M. Miller, T. B. Thornley, T. Pearson, A. J. Kruger, M. Yamazaki, L. D. Shultz, R. M. Welsh, M. A. Brehm, A. A. Rossini, and D. L. Greiner
TLR Agonists Prevent the Establishment of Allogeneic Hematopoietic Chimerism in Mice Treated with Costimulation Blockade
J. Immunol., May 1, 2009; 182(9): 5547 - 5559.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. Kurtz, F. Raval, C. Vallot, J. Der, and M. Sykes
CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote tolerance
Blood, April 9, 2009; 113(15): 3475 - 3484.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. Mangada, T. Pearson, M. A. Brehm, L. S. Wicker, L. B. Peterson, L. D. Shultz, D. V. Serreze, A. A. Rossini, and D. L. Greiner
Idd Loci Synergize to Prolong Islet Allograft Survival Induced by Costimulation Blockade in NOD Mice
Diabetes, January 1, 2009; 58(1): 165 - 173.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. C. Gondek, V. DeVries, E. C. Nowak, L.-F. Lu, K. A. Bennett, Z. A. Scott, and R. J. Noelle
Transplantation Survival Is Maintained by Granzyme B+ Regulatory Cells and Adaptive Regulatory T Cells
J. Immunol., October 1, 2008; 181(7): 4752 - 4760.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Wei, H. Wang, B. Lu, B. Li, S. Hou, W. Qian, K. Fan, J. Dai, J. Zhao, and Y. Guo
Cancer Immunotherapy Using In vitro Genetically Modified Targeted Dendritic Cells
Cancer Res., May 15, 2008; 68(10): 3854 - 3862.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
H. Xu, J. Yan, Y. Huang, P. M. Chilton, C. Ding, C. L. Schanie, L. Wang, and S. T. Ildstad
Costimulatory blockade of CD154-CD40 in combination with T-cell lymphodepletion results in prevention of allogeneic sensitization
Blood, March 15, 2008; 111(6): 3266 - 3275.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. B. Thornley, N. E. Phillips, B. C. Beaudette-Zlatanova, T. G. Markees, K. Bahl, M. A. Brehm, L. D. Shultz, E. A. Kurt-Jones, J. P. Mordes, R. M. Welsh, et al.
Type 1 IFN Mediates Cross-Talk between Innate and Adaptive Immunity That Abrogates Transplantation Tolerance
J. Immunol., November 15, 2007; 179(10): 6620 - 6629.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
L. K. Selin and M. A. Brehm
Frontiers in Nephrology: Heterologous Immunity, T Cell Cross-Reactivity, and Alloreactivity
J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2268 - 2277.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Li, L. Ma, J. Shen, and A. S. Chong
Peripheral deletion of mature alloreactive B cells induced by costimulation blockade
PNAS, July 17, 2007; 104(29): 12093 - 12098.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. G. H. Hernandez, L. Shen, and K. L. Rock
CD40-CD40 Ligand Interaction between Dendritic Cells and CD8+ T Cells Is Needed to Stimulate Maximal T Cell Responses in the Absence of CD4+ T Cell Help
J. Immunol., March 1, 2007; 178(5): 2844 - 2852.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Zhai, L. Meng, F. Gao, Y. Wang, R. W. Busuttil, and J. W. Kupiec-Weglinski
CD4+ T Regulatory Cell Induction and Function in Transplant Recipients after CD154 Blockade Is TLR4 Independent
J. Immunol., May 15, 2006; 176(10): 5988 - 5994.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. B. Thornley, M. A. Brehm, T. G. Markees, L. D. Shultz, J. P. Mordes, R. M. Welsh, A. A. Rossini, and D. L. Greiner
TLR Agonists Abrogate Costimulation Blockade-Induced Prolongation of Skin Allografts
J. Immunol., February 1, 2006; 176(3): 1561 - 1570.
[Abstract] [Full Text] [PDF]

Home page
 Phil Trans R Soc BHome page
S. P Cobbold
T cell tolerance induced by therapeutic antibodies
Phil Trans R Soc B, September 29, 2005; 360(1461): 1695 - 1705.
[Abstract] [Full Text] [PDF]

Home page
 Phil Trans R Soc BHome page
D. A Hale, K. Dhanireddy, D. Bruno, and A. D Kirk
Induction of transplantation tolerance in non-human primate preclinical models
Phil Trans R Soc B, September 29, 2005; 360(1461): 1723 - 1737.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Sho, K. Kishimoto, H. Harada, M. Livak, A. Sanchez-Fueyo, A. Yamada, X. X. Zheng, T. B. Strom, G. P. Basadonna, M. H. Sayegh, et al.
Requirements for induction and maintenance of peripheral tolerance in stringent allograft models
PNAS, September 13, 2005; 102(37): 13230 - 13235.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. A. Quezada, K. Bennett, B. R. Blazar, A. Y. Rudensky, S. Sakaguchi, and R. J. Noelle
Analysis of the Underlying Cellular Mechanisms of Anti-CD154-Induced Graft Tolerance: The Interplay of Clonal Anergy and Immune Regulation
J. Immunol., July 15, 2005; 175(2): 771 - 779.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. C. Ochando, A. C. Yopp, Y. Yang, A. Garin, Y. Li, P. Boros, J. Llodra, Y. Ding, S. A. Lira, N. R. Krieger, et al.
Lymph Node Occupancy Is Required for the Peripheral Development of Alloantigen-Specific Foxp3+ Regulatory T Cells
J. Immunol., June 1, 2005; 174(11): 6993 - 7005.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. T. Ildstad, P. M. Chilton, H. Xu, M. A. Domenick, and M. B. Ray
Preconditioning of NOD mice with anti-CD8 mAb and costimulatory blockade enhances chimerism and tolerance and prevents diabetes, while depletion of {alpha}{beta}-TCR+ and CD4+ cells negates the effect
Blood, March 15, 2005; 105(6): 2577 - 2584.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Yamada, A. D. Salama, M. Sho, N. Najafian, T. Ito, J. P. Forman, R. Kewalramani, S. Sandner, H. Harada, M. R. Clarkson, et al.
CD70 Signaling Is Critical for CD28-Independent CD8+ T Cell-Mediated Alloimmune Responses In Vivo
J. Immunol., February 1, 2005; 174(3): 1357 - 1364.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
E. J. Gordon, L. S. Wicker, L. B. Peterson, D. V. Serreze, T. G. Markees, L. D. Shultz, A. A. Rossini, D. L. Greiner, and J. P. Mordes
Autoimmune Diabetes and Resistance to Xenograft Transplantation Tolerance in NOD Mice
Diabetes, January 1, 2005; 54(1): 107 - 115.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. Metzler, P. Gfeller, M. Bigaud, J. Li, G. Wieczorek, C. Heusser, P. Lake, and A. Katopodis
Combinations of Anti-LFA-1, Everolimus, Anti-CD40 Ligand, and Allogeneic Bone Marrow Induce Central Transplantation Tolerance through Hemopoietic Chimerism, Including Protection from Chronic Heart Allograft Rejection
J. Immunol., December 1, 2004; 173(11): 7025 - 7036.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
K. Kishimoto, X. Yuan, H. Auchincloss Jr., A. H. Sharpe, D. A. Mandelbrot, and M. H. Sayegh
Mechanism of Action of Donor-Specific Transfusion in Inducing Tolerance: Role of Donor MHC Molecules, Donor Co-stimulatory Molecules, and Indirect Antigen Presentation
J. Am. Soc. Nephrol., September 1, 2004; 15(9): 2423 - 2428.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
T. Pearson, P. Weiser, T. G. Markees, D. V. Serreze, L. S. Wicker, L. B. Peterson, A.-M. Cumisky, L. D. Shultz, J. P. Mordes, A. A. Rossini, et al.
Islet Allograft Survival Induced by Costimulation Blockade in NOD Mice Is Controlled by Allelic Variants of Idd3
Diabetes, August 1, 2004; 53(8): 1972 - 1978.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. J. Nathan, J. E. Mold, S. C. Wood, K. Csencsits, G. Lu, E. J. Eichwald, and D. K. Bishop
Requirement for Donor and Recipient CD40 Expression in Cardiac Allograft Rejection: Induction of Th1 Responses and Influence of Donor-Derived Dendritic Cells
J. Immunol., June 1, 2004; 172(11): 6626 - 6633.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. Kurtz, J. Shaffer, A. Lie, N. Anosova, G. Benichou, and M. Sykes
Mechanisms of early peripheral CD4 T-cell tolerance induction by anti-CD154 monoclonal antibody and allogeneic bone marrow transplantation: evidence for anergy and deletion but not regulatory cells
Blood, June 1, 2004; 103(11): 4336 - 4343.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Chen, P. S. Heeger, and A. Valujskikh
In Vivo Helper Functions of Alloreactive Memory CD4+ T Cells Remain Intact Despite Donor-Specific Transfusion and Anti-CD40 Ligand Therapy
J. Immunol., May 1, 2004; 172(9): 5456 - 5466.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. van Maurik, B. F. de St. Groth, K. J. Wood, and N. D. Jones
Dependency of Direct Pathway CD4+ T Cells on CD40-CD154 Costimulation Is Determined by Nature and Microenvironment of Primary Contact with Alloantigen
J. Immunol., February 15, 2004; 172(4): 2163 - 2170.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
N. A. Turgeon, S. J. Banuelos, L. D. Shultz, B. L. Lyons, N. Iwakoshi, D. L. Greiner, J. P. Mordes, A. A. Rossini, and M. C. Appel
Alloimmune Injury and Rejection of Human Skin Grafts on Human Peripheral Blood Lymphocyte-Reconstituted Non-Obese Diabetic Severe Combined Immunodeficient {beta}2-Microglobulin-Null Mice
Experimental Biology and Medicine, October 1, 2003; 228(9): 1096 - 1104.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Pearson, T. G. Markees, D. V. Serreze, M. A. Pierce, M. P. Marron, L. S. Wicker, L. B. Peterson, L. D. Shultz, J. P. Mordes, A. A. Rossini, et al.
Genetic Disassociation of Autoimmunity and Resistance to Costimulation Blockade-Induced Transplantation Tolerance in Nonobese Diabetic Mice
J. Immunol., July 1, 2003; 171(1): 185 - 195.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
P. Blaha, S. Bigenzahn, Z. Koporc, M. Schmid, F. Langer, E. Selzer, H. Bergmeister, F. Wrba, J. Kurtz, C. Kiss, et al.
The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade
Blood, April 1, 2003; 101(7): 2886 - 2893.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. E. Phillips, T. G. Markees, J. P. Mordes, D. L. Greiner, and A. A. Rossini
Blockade of CD40-Mediated Signaling Is Sufficient for Inducing Islet But Not Skin Transplantation Tolerance
J. Immunol., March 15, 2003; 170(6): 3015 - 3023.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Xu, S. P. Montgomery, E. H. Preston, D. K. Tadaki, D. A. Hale, D. M. Harlan, and A. D. Kirk
Studies Investigating Pretransplant Donor-Specific Blood Transfusion, Rapamycin, and the CD154-Specific Antibody IDEC-131 in a Nonhuman Primate Model of Skin Allotransplantation
J. Immunol., March 1, 2003; 170(5): 2776 - 2782.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
T. Pearson, T. G. Markees, L. S. Wicker, D. V. Serreze, L. B. Peterson, J. P. Mordes, A. A. Rossini, and D. L. Greiner
NOD Congenic Mice Genetically Protected From Autoimmune Diabetes Remain Resistant to Transplantation Tolerance Induction
Diabetes, February 1, 2003; 52(2): 321 - 326.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Yin, N. Dujovny, L. Ma, A. Varghese, J. Shen, D. K. Bishop, and A. S. Chong
IFN-{gamma} Production Is Specifically Regulated by IL-10 in Mice Made Tolerant with Anti-CD40 Ligand Antibody and Intact Active Bone
J. Immunol., January 15, 2003; 170(2): 853 - 860.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. R. Nicolls, M. Coulombe, J. Beilke, H. C. Gelhaus, and R. G. Gill
CD4-Dependent Generation of Dominant Transplantation Tolerance Induced by Simultaneous Perturbation of CD154 and LFA-1 Pathways
J. Immunol., November 1, 2002; 169(9): 4831 - 4839.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. J. Young, L. Yang, M. J. Phillips, and L. Zhang
Donor-lymphocyte infusion induces transplantation tolerance by activating systemic and graft-infiltrating double-negative regulatory T cells
Blood, October 16, 2002; 100(9): 3408 - 3414.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. Pantenburg, F. Heinzel, L. Das, P. S. Heeger, and A. Valujskikh
T Cells Primed by Leishmania major Infection Cross-React with Alloantigens and Alter the Course of Allograft Rejection
J. Immunol., October 1, 2002; 169(7): 3686 - 3693.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. N. Iwakoshi, T. G. Markees, N. Turgeon, T. Thornley, A. Cuthbert, J. Leif, N. E. Phillips, J. P. Mordes, D. L. Greiner, and A. A. Rossini4
Skin Allograft Maintenance in a New Synchimeric Model System of Tolerance
J. Immunol., December 1, 2001; 167(11): 6623 - 6630.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Ferrari-Lacraz, X. X. Zheng, Y. S. Kim, Y. Li, W. Maslinski, X. C. Li, and T. B. Strom
An Antagonist IL-15/Fc Protein Prevents Costimulation Blockade-Resistant Rejection
J. Immunol., September 15, 2001; 167(6): 3478 - 3485.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
P. A. Taylor, C. J. Lees, H. Waldmann, R. J. Noelle, and B. R. Blazar
Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions
Blood, July 15, 2001; 98(2): 467 - 474.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Ito, J. Kurtz, J. Shaffer, and M. Sykes
CD4 T Cell-Mediated Alloresistance to Fully MHC-Mismatched Allogeneic Bone Marrow Engraftment Is Dependent on CD40-CD40 Ligand Interactions, and Lasting T Cell Tolerance Is Induced by Bone Marrow Transplantation with Initial Blockade of this Pathway
J. Immunol., March 1, 2001; 166(5): 2970 - 2981.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. A. Williams, J. Trambley, J. Ha, A. B. Adams, M. M. Durham, P. Rees, S. R. Cowan, T. C. Pearson, and C. P. Larsen
Genetic Characterization of Strain Differences in the Ability to Mediate CD40/CD28-Independent Rejection of Skin Allografts
J. Immunol., December 15, 2000; 165(12): 6849 - 6857.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. D. Jones, A. Van Maurik, M. Hara, B. M. Spriewald, O. Witzke, P. J. Morris, and K. J. Wood
CD40-CD40 Ligand-Independent Activation of CD8+ T Cells Can Trigger Allograft Rejection
J. Immunol., July 15, 2000; 165(2): 1111 - 1118.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.